Inferiority of Vancomycin Dosing and Design?
نویسندگان
چکیده
منابع مشابه
[Vancomycin dosing in hemodialysis patients].
UNLABELLED Vancomycin is widely used in haemodialysis (HD) patients for treating infections of vascular access due to St. Aureus. To avoid subtherapeutic levels it is important to know the adequate dosing in patients undergoing haemodialysis with high flux membranes. OBJECTIVE The aim of this study was to evaluate whether HD patients treated with 1 g intravenous (IV) vancomycin reached optimu...
متن کاملVancomycin Dosing in Neutropenic Patients
BACKGROUND To compare vancomycin pharmacokinetic parameters in patients with and without neutropenia. METHODS Patients ≥18 years admitted on general wards were included. Routinely vancomycin trough and peak plasma concentrations were measured with a fluorescence polarization immunoassay. Pharmacokinetic parameters of individual patients were determined with maximum a posterior Bayesian estima...
متن کاملvancomycin utilization evaluation: are we dosing appropriately?
background : inappropriate use of vancomycin not only increase health care costs but also contribute to the emergence of resistant organisms. higher trough serum vancomycin concentrations (>10mg/l) has been recommended for avoidance of development of resistance. we aim to compare the administered dose with recommended doses based on guideline-recommended weight-based dosing. methods : in a cros...
متن کاملInfluence of age on frequency of vancomycin dosing.
BACKGROUND Vancomycin is commonly prescribed at the authors' institution because of a high prevalence of invasive infections caused by methicillin-resistant Staphylococcus aureus (MRSA) in a generally younger population. The most commonly prescribed empiric dosing interval is every 12 h (q12h). However, observations have suggested that younger adult patients require more frequent dosing, such a...
متن کاملAssessment of Initial Vancomycin Dosing in Pediatric Oncology Patients
This was a retrospective audit assessing vancomycin dosing of 60 mg/kg/day in the attainment of therapeutic concentrations between 10-20 mcg/mL among 56 pediatric oncology patients. Twelve patients (21%) achieved therapeutic concentrations of 10-20 mcg/mL, while 44 patients (79%) obtained trough levels below 10 mcg/mL despite the addition of nephrotoxic agents.
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Clinical Infectious Diseases
سال: 2015
ISSN: 1058-4838,1537-6591
DOI: 10.1093/cid/civ024